Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIV.
Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIV.
复制标题
表型衰老标志物与艾滋病病毒感染者的共病、衰弱和炎症标志物的关联
DOI:
10.1186/s12877-022-03720-1
复制
发表时间:
2022-12-31
期刊:
影响因子:
4.1
通讯作者:
Avihingsanon, Anchalee
中科院分区:
文献类型:
--
作者:
Han, Win Min;Apornpong, Tanakorn;Gatechompol, Sivaporn;Ubolyam, Sasiwimol;Chattranukulchai, Pairoj;Wattanachanya, Lalita;Siwamogsatham, Sarawut;Kerr, Stephen J.;Erlandson, Kristine M.;Avihingsanon, Anchalee
Aging characteristics in people living with HIV (PLWH) are heterogeneous, and the identification of risk factors associated with aging-related comorbidities such as neurocognitive impairment (NCI) and frailty is important. We evaluated predictors of novel aging markers, phenotypic age (PhenoAge) and phenotypic age acceleration (PAA) and their association with comorbidities, frailty, and NCI. In a cohort of PLWH and age- and sex-matched HIV-negative controls, we calculated PhenoAge using chronological age and 9 biomarkers from complete blood counts, inflammatory, metabolic-, liver- and kidney-related parameters. PAA was calculated as the difference between chronological age and PhenoAge. Multivariate logistic regression models were used to identify the factors associated with higher (>median) PAA. Area under the receiver operating characteristics curve (AUROC) was used to assess model discrimination for frailty. Among 333 PLWH and 102 HIV-negative controls (38% female), the median phenotypic age (49.4 vs. 48.5 years, p = 0.54) and PAA (− 6.7 vs. -7.5, p = 0.24) was slightly higher and PAA slightly less in PLWH although this did not reach statistical significance. In multivariate analysis, male sex (adjusted odds ratio = 1.68 [95%CI = 1.03–2.73]), current smoking (2.74 [1.30–5.79]), diabetes mellitus (2.97 [1.48–5.99]), hypertension (1.67 [1.02–2.72]), frailty (3.82 [1.33–10.93]), and higher IL-6 levels (1.09 [1.04–1.15]), but not HIV status and NCI, were independently associated with higher PAA. PhenoAge marker discriminated frailty better than chronological age alone (AUROC: 0.75 [0.66–0.85] vs. 0.65 [0.55–0.77], p = 0.04). In the analysis restricted to PLWH, PhenoAge alone predicted frailty better than chronological age alone (AUROC: 0.7412 vs. 0.6499, P = 0.09) and VACS index (AUROC: 0.7412 vs. 0.6811, P = 0.34) despite not statistically significant. While PLWH did not appear to have accelerated aging in our cohort, the phenotypic aging marker was significantly associated with systemic inflammation, frailty, and cardiovascular disease risk factors. This simple aging marker could be useful to identify high-risk PLWH within a similar chronological age group. The online version contains supplementary material available at 10.1186/s12877-022-03720-1.
登录
查看更多内容
DOI:
10.1093/infdis/jiv277
发表时间:
2015-11-15
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Horvath S;Levine AJ
通讯作者:
Levine AJ
影响因子:
16
作者:
Gross AM;Jaeger PA;Kreisberg JF;Licon K;Jepsen KL;Khosroheidari M;Morsey BM;Swindells S;Shen H;Ng CT;Flagg K;Chen D;Zhang K;Fox HS;Ideker T
通讯作者:
Ideker T
影响因子:
5.4
作者:
Alonso, Alvaro;Barnes, A. Elise;Marconi, Vincent
通讯作者:
Marconi, Vincent
影响因子:
6.4
作者:
Borges, Alvaro H.;O'Connor, Jemma L.;Lundgren, Jens D.
通讯作者:
Lundgren, Jens D.
DOI:
10.1093/gerona/56.3.m158
发表时间:
2001-03-01
影响因子:
5.1
作者:
Newman, AB;Gottdiener, JS;Fried, LP
通讯作者:
Fried, LP